Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Journal for Immunotherapy of Cancer|November 23, 2017
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working GroupI Puzanov, A Diab, K Abdallah, et al.
The British Journal of Nutrition|May 1, 1986
The efficiency of energy utilization in growing cattle consuming fresh perennial ryegrass (Lolium perenne cv. Melle) or white clover (Trifolium repens cv. Blanca)S B Cammell, D J Thomson, D E Beever, et al.
The Journal of Infectious Diseases|January 1, 1994
Clinical safety, tolerability, and pharmacokinetics of murine monoclonal antibody to human tumor necrosis factor-alphaL D Saravolatz, J C Wherry, C Spooner, et al.
Osteoarthritis and Cartilage|July 19, 2018
Factors associated with the orthopaedic surgeon's decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1905 patientsC Huynh, D Puyraimond-Zemmour, J F Maillefert, et al.
International Journal of Cardiology|November 11, 2017
Quality of life improvement in older patients with heart failure initiated on ivabradine: Results from the UK multi-centre LIVE:LIFE prospective cohort studyD Zachariah, D Stevens, G Sidorowicz, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
Novel inhibitors of AP-1 and NF-kappaB mediated gene expression: structure-activity relationship studies of ethyl 4-[(3-methyl-2,5-dioxo(3-pyrrolinyl))amino]-2-(trifluoromethyl)++ +pyrimidi ne-5-carboxylateM S Palanki, P E Erdman, A M Manning, et al.
Osteoarthritis and Cartilage|November 4, 2010
The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacementL Gossec, S Paternotte, J F Maillefert, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
14-3-3 promotes sarcolemmal expression of cardiac Ca V 1.2 and nucleates isoproterenol-triggered channel super-clusteringHeather C Spooner, Alexandre D Costa, Adriana Hernández González, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2021
β-Adrenergic control of sarcolemmal CaV1.2 abundance by small GTPase Rab proteinsSilvia G Del Villar, Taylor L Voelker, Maartje Westhoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2025
14-3-3 promotes sarcolemmal expression of cardiac CaV1.2 and nucleates isoproterenol-triggered channel superclusteringHeather C Spooner, Alexandre D Costa, Maartje Westhoff, et al.
Pageof 13